Q32 Bio launches USD 200 million stock offering with pre-funded warrants option

PUBT · 1d ago
Q32 Bio launches USD 200 million stock offering with pre-funded warrants option
  • Q32 Bio launched an underwritten public offering of USD 200 million in common stock, including pre-funded warrants in lieu of shares for some investors.
  • Underwriters received a 30-day option to buy up to an additional USD 30 million of common stock.
  • Proceeds earmarked for working capital, including R&D and advancing bempikibart into future clinical trials.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607131601PR_NEWS_USPR_____NE03495) on July 13, 2026, and is solely responsible for the information contained therein.